These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19373781)

  • 1. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
    Feinberg-Gorenshtein G; Avigad S; Jeison M; Halevy-Berco G; Mardoukh J; Luria D; Ash S; Steinberg R; Weizman A; Yaniv I
    Genes Chromosomes Cancer; 2009 Jul; 48(7):539-43. PubMed ID: 19373781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
    Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-34 family in cancer and apoptosis.
    Hermeking H
    Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
    Chen X; Yan J; Chen T
    Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
    Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
    Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
    Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
    Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
    Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
    Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
    J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
    Chen F; Hu SJ
    J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors.
    Abel F; Sjöberg RM; Krona C; Nilsson S; Martinsson T
    Int J Oncol; 2004 Nov; 25(5):1297-302. PubMed ID: 15492818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene.
    Cole KA; Attiyeh EF; Mosse YP; Laquaglia MJ; Diskin SJ; Brodeur GM; Maris JM
    Mol Cancer Res; 2008 May; 6(5):735-42. PubMed ID: 18505919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma.
    Metheetrairut C; Chotigavanich C; Amornpichetkul K; Keskool P; Ongard S; Metheetrairut C
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):521-533. PubMed ID: 30515607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer.
    Ecke TH; Schlechte HH; Gunia S; Lenk SV; Loening SA
    Urol Oncol; 2008; 26(5):470-3. PubMed ID: 18367114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.